Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £110.00. The company’s shares opened today at p10,500. ...

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p15,318.00.

AstraZeneca PLC closed 24.89% short of its 52-week high of £133.88, which the company achieved on September 3rd.

AstraZeneca Pharmaceuticals LP and a Christian sales specialist have agreed to settle his suit over the company’s failure to ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer (NSCLC) at high ...

Under the plans, AstraZeneca’s small molecule and biologics R&D activities were concentrated in three strategic centres. Firstly, the company invested approximately $500 million to establish a ...

Regina Fritsche Danielson, vice president and head of cardiovascular, renal and metabolism, AstraZeneca R&D Regina Fritsche-Danielson is accountable for both the small-molecule and new modalities ...

One bright spot for Chancellor Rachel Reeves is the fact the British economy is 75% services – left untouched by the tariffs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

DelveInsight's "TIBSOVO Market Size, Forecast, and Market Insight Report" highlights the details around TIBSOVO, the first ...

Learn how to cut stainless steel effectively with methods like laser, plasma, mechanical, and water jet cutting. Compare ...

Nuclear energy's role in reducing carbon emissions and high efficiency makes it a significant player in the clean energy ...